Thyroid hormones and stroke, the gap between clinical and experimental studies

• الحاوية / القاعدة: Brain Research Bulletin
• المؤلفون الرئيسيون: Sakineh Shafia, Ashraf Khoramirad, Kobra Akhoundzadeh
• التنسيق: مقال
• اللغة: الإنجليزية
• منشور في: Elsevier 2024-07-01
• الموضوعات: Stroke; Cerebral ischemia; Brain ischemia; Triiodothyronine (T3); Thyroxine (T4); Thyroid hormone
• الوصول للمادة أونلاين: http://www.sciencedirect.com/science/article/pii/S0361923024001163

Despite plenty of human studies on changes in thyroid hormones after stroke and some animal studies that assessed the effects of thyroid hormone administration on stroke, conclusive evidence for clinical application is lacking. This review aimed to determine the consistency of the results between clinical and preclinical studies. This article reviewed the PubMed, Embase, web of Knowledge, and Google Scholar databases up to June 2023 using the MeSH terms “stroke, cerebral ischemia, cerebral infarction, brain ischemia, brain infarction, triiodothyronine (T3), tetraiodothyronine (T4), thyroxine (T4), and thyroid hormone''. The results of clinical and preclinical studies related to T3 substantially confirm each other. That is, in most human studies lower T3 was associated with poor outcomes, and in experimental studies, T3 administration also had therapeutic effects. However, the results of experimental studies related to T4 could not support those of clinical studies. There seem to be some conflicts between experimental and human studies, especially regarding changes and effects of T4 after stroke. The gap between experimental and clinical studies may lead to non-applicable results, wasting time and money, and unnecessary killing of animals.